Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2019 Feb 28;7(5):782-785.
doi: 10.3889/oamjms.2019.181. eCollection 2019 Mar 15.

Scleromyxedema (Arndt - Gottron Syndrome) Developing Under Tenofovir Treatment for Hepatitis B: Unique Presentation in a Bulgarian Patient!

Affiliations
Case Reports

Scleromyxedema (Arndt - Gottron Syndrome) Developing Under Tenofovir Treatment for Hepatitis B: Unique Presentation in a Bulgarian Patient!

Ivanka Temelkova et al. Open Access Maced J Med Sci. .

Abstract

Background: Scleromyxedema, also referred to as the Arndt-Gottron (S-AG) syndrome or the systemic form of Lichen myxedematosus (LM), is a cutaneous mucinosis with a chronic course and high lethality from systemic involvement of other organs and systems. Interesting in several aspects is the association between scleromyxedema and viral hepatitis about: 1) hepatitis virus infection as a possible etiological factor for the development of scleromyxedema, 2) antiretroviral therapy for the treatment of hepatitis as a method of reversing scleromyxedema and 3) antiviral drugs as inducers of scleromyxedema.

Case report: We present a 53-year old patient who for nine months had been on tenofovir disoproxil 245 mg (0-0-1) therapy for chronic hepatitis B. Three months after the start of antiviral therapy (i.e. for a period of 6 months), the patient observed swelling, itching and hardening of the skin on the face, ears and hands, which subsequently spread throughout the trunk. Subsequent histological study of a skin biopsy revealed changes of scleromyxedema at an advanced stage, though immunoelectrophoresis of serum and urine excluded the presence of paraproteinaemia or para proteinuria. Systemic antihistamine and topical corticosteroid therapy were instituted. Bone involvement with possible plasmacytoma was excluded, and a myelogram showed evidence of an erythroblastic reaction of bone marrow.

Conclusion: We believe that drug-induced scleromyxedema is a rare but possible phenomenon. We describe the first case of tenofovir-induced scleromyxedema within the framework of chronic hepatitis B treatment.

Keywords: Arndt - Gottron syndrome; Diabetes mellitus; Hepatitis B; Pathogenetic relationship; Scleromyxedema; Survival benefit; Tenofovir; Treatment.

PubMed Disclaimer

Figures

Figure 1
Figure 1
a) Hardening of the face skin; b) Skin-colored small papules on the ear skin; c) Hardening of the skin on the back and neck; d) Multiple disseminated papules on the skin of the hands and arthropathy
Figure 2
Figure 2
a) This skin biopsy shows a combination of numerous fibroblasts, mucin, and irregularly arranged collagen bundles; b) At higher magnification, there are irregularly arranged collagen and scattered spindled cells, representing fibroblasts, within a mucinous background; c) This image shows details of fibroblasts around the cross-sectional profile of an eccrine sweat duct

Similar articles

References

    1. Rongioletti F, Rebora A. Updated classification of papular mucinosis, lichen myxedematosus, and scleromyxedema. J Am Acad Dermatol. 2001;44(2):273–81. https://doi.org/10.1067/mjd.2001.111630 PMid:11174386. - PubMed
    1. Sala A, Cunha P, Pinto C, Alves C, Paiva I, Araujo A. Scleromyxedema:clinical diagnosis and autopsy findings. A Bras Dermatol. 2016;91(5 Suppl 1):48–50. https://doi.org/10.1590/abd1806-4841.20164527 PMid:28300892 PMCid:PMC5324991. - PMC - PubMed
    1. Saniee S, Davarnia G. Scleromyxedema without Paraproteinemia:Treatment with Thalidomide and Prednisolone. Case Rep Dermatol. 2016;8(3):327–332. https://doi.org/10.1159/000452319 PMid:27990110 PMCid:PMC5156886. - PMC - PubMed
    1. Rongioletti F, Merlo G, Cinotti E, Fausti V, Cozzani E, Cribier B, Metze D, Calonje E, Kanitakis J, Kempf W, Stefanato C, Marinho E, Parodi A. Scleromyxedema:a multicenter study of characteristics, comorbidities, course, and therapy in 30 patients. J Am Acad Dermatol. 2013;69(1):66–72. https://doi.org/10.1016/j.jaad.2013.01.007 PMid:23453242. - PubMed
    1. Smith J, Kalimullah F, Erickson C, Peng L. Scleromyxedema secondary to hepatitis C virus and successfully treated with antiviral therapy. Dermatol Online J. 2015;21(9) - PubMed

Publication types

LinkOut - more resources